Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Benouaich-Amiel

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Neurosurgery|July 4, 2025
Let the light in: influence of fluorescence-guided resection with 5-aminolevulinic acid on surgical outcomes, extent of resection, and survival in subventricular zone glioblastomaYosef Laviv, Paz Lev, Sapir Lev, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|November 3, 2023
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme PhenotypeYosef Laviv, Eilat Sapirstein, Andrew A Kanner, et al.
Journal of Neuro-Oncology|March 12, 2025
Long-term impact of bevacizumab for the treatment of brain radiation necrosisHila Nobel, Jonathan Ofer, Sara Faye Borenstein, et al.
Cancer|March 29, 2006
Prognostic impact of molecular markers in a series of 220 primary glioblastomasCaroline Houillier, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Journal of Neuro-Oncology|August 30, 2017
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastomaJay-Jiguang Zhu, Petya Demireva, Andrew A Kanner, et al.
Asian Journal of Neurosurgery|July 2, 2021
The Impact of Surgery on the Survival of Patients with Recurrent GlioblastomaOumar Sacko, Alexandra Benouaich-Amiel, Pierre Brandicourt, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 14, 2021
Multicentric non-enhancing lesions in glioblastoma: A retrospective studyAlexandra Benouaich-Amiel, Vadim Khasminsky, Omer Gal, et al.
Annals of Neurology|December 29, 2006
MGMT methylation: a marker of response to temozolomide in low-grade gliomasSibille Everhard, Gentian Kaloshi, Emmanuelle Crinière, et al.
Cancer|September 21, 2006
Prognostic stratification of patients with anaplastic gliomas according to genetic profileCaroline Dehais, Florence Laigle-Donadey, Yannick Marie, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neurosurgery|July 4, 2025
Let the light in: influence of fluorescence-guided resection with 5-aminolevulinic acid on surgical outcomes, extent of resection, and survival in subventricular zone glioblastomaYosef Laviv, Paz Lev, Sapir Lev, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|November 3, 2023
Significant Systemic Insulin Resistance is Associated With Unique Glioblastoma Multiforme PhenotypeYosef Laviv, Eilat Sapirstein, Andrew A Kanner, et al.
Journal of Neuro-Oncology|March 12, 2025
Long-term impact of bevacizumab for the treatment of brain radiation necrosisHila Nobel, Jonathan Ofer, Sara Faye Borenstein, et al.
Cancer|March 29, 2006
Prognostic impact of molecular markers in a series of 220 primary glioblastomasCaroline Houillier, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Journal of Neuro-Oncology|August 30, 2017
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastomaJay-Jiguang Zhu, Petya Demireva, Andrew A Kanner, et al.
Asian Journal of Neurosurgery|July 2, 2021
The Impact of Surgery on the Survival of Patients with Recurrent GlioblastomaOumar Sacko, Alexandra Benouaich-Amiel, Pierre Brandicourt, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 14, 2021
Multicentric non-enhancing lesions in glioblastoma: A retrospective studyAlexandra Benouaich-Amiel, Vadim Khasminsky, Omer Gal, et al.
Annals of Neurology|December 29, 2006
MGMT methylation: a marker of response to temozolomide in low-grade gliomasSibille Everhard, Gentian Kaloshi, Emmanuelle Crinière, et al.
Cancer|September 21, 2006
Prognostic stratification of patients with anaplastic gliomas according to genetic profileCaroline Dehais, Florence Laigle-Donadey, Yannick Marie, et al.
Pageof 4